{"database": "openregs", "table": "dockets", "rows": [["FDA-2003-P-0126", "FDA", "Requesting the Agency to Permit the Fling of an ANDA for A Drug Product (1.5 mg Levonorgestrel Tablet) Which is Not Indentical to the Reference Listed Drug (Plan B 0.75 mg Levonorgestrel Tablet) In Strength-CLOSED", "Nonrulemaking", "2021-09-01T01:02:56Z", "0b00006480486135"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-P-0126"], "units": {}, "query_ms": 0.39491499774158, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}